Meyka Pro banner
AstraZeneca PLC ADRhedged

AstraZeneca PLC ADRhedged (AZNH) Stock Overview

Explore AstraZeneca PLC ADRhedged’s financial performance, market position, analyst ratings, and future outlook.

AZNHAMEX
HealthcareMedical - Pharmaceuticals
$53.74
$0.01(0.03%)
U.S. Market opens in 11h 41m

AstraZeneca PLC ADRhedged (AZNH)

Meyka AI Score

Z

Key Financials

Market Cap1.6M
P/E RatioN/A
EPS (TTM)$1.40
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$75.09

AZNH Stock Analysis & Investment Overview (AMEX)

Our AI-powered analysis of AstraZeneca PLC ADRhedged (AMEX: AZNH) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, AstraZeneca PLC ADRhedged's AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AZNH on the AMEX shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $75.09 for the AMEX listing.

Key metrics behind AstraZeneca PLC ADRhedged's AMEX-traded stock include a P/E ratio of N/A and a market capitalization of 1.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AZNH on the AMEX.

Price Performance (AMEX: AZNH)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.02%
3-Month Change
-4.43%
6-Month Change
12.31%
Year-to-Date (YTD) Change
-0.65%
1-Year Change
10.30%
3-Year Change
8.26%
5-Year Change
8.26%
All-Time (Max) Change
8.26%

Contact Information

908-781-0560
301 South State Street, Suite N-002, Newtown, PA, 18940

Company Facts

IPO DateOct 7, 2024
CountryUS

Frequently Asked Questions